In order to assess the relevance of the PDGF/Abl pathway we interrogated global gene transcription data from two publically available global gene transcription data sets from ER+ breast cancer cell lines (ZR-75.1, MDA MB 361 and HCC-1428) that had been adapted to LTED [11,15]. The gene discussed is ABL1; the disease is breast carcinoma.